This research demonstrates scalable nanoemulsion formation using low-energy phase inversion, suggesting practical applications in formulation.
Nanoemulsions are widely recognized as versatile delivery platforms capable of stably loading lipophilic active ingredients. Although low-energy phase inversion methods enable nanoemulsion formation under ambient and low-shear conditions, their scalability and applicability in practical formulation environments remain insufficiently validated. Here, we develop oil-in-water (O/W) nanoemulsions via a low-energy phase inversion process and systematically investigate their composition-dependent formation, scalability, and formulation stability. By precisely tuning the composition of a mixed nonionic surfactant system, monodisperse nanoemulsions with an average droplet size of ~110 nm and a polydispersity index (PDI ≤ 0.20) are reproducibly obtained under ambient, low-shear conditions. The optimized nanoemulsions maintain their nanoscale dispersion characteristics over 30 days of storage and exhibit consistent droplet size and distribution upon scale-up to 1 L. Furthermore, the nanoemulsions retain structural stability when incorporated into polymer-based formulations under various temperature conditions and repeated thermal cycling. These results demonstrate that low-energy phase inversion enables a scalable and formulation-compatible nanoemulsion platform, providing practical guidelines for industrial formulation and manufacturing of delivery systems for lipophilic active ingredients.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: